Fulgent Genetics (MEX:FLGT) Other Current Receivables: MXN116 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:FLGT Fulgent Genetics Inc MEX:FLGT
56 GF Score
Price MXN372.00
GF Value MXN734.64
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Fulgent Genetics Other Current Receivables?

Fulgent Genetics MEX:FLGT 56 Other Current Receivables is MXN116 Mil as of Mar. 2026. GuruFocus rates MEX:FLGT with a GF Score™ of 56/100 and a GF Value™ of MXN734.64 (Possible Value Trap). The stock has 4 warning signs investors should review.

Fulgent Genetics's Other Current Receivables for the quarter that ended in Mar. 2026 was MXN116 Mil.

Fulgent Genetics's quarterly Other Current Receivables declined from Sep. 2025 (MXN138.10 Mil) to Dec. 2025 (MXN123.30 Mil) but then stayed the same from Dec. 2025 (MXN123.30 Mil) to Mar. 2026 (MXN116.47 Mil).

Fulgent Genetics's annual Other Current Receivables increased from Dec. 2023 (MXN107.16 Mil) to Dec. 2024 (MXN167.03 Mil) but then declined from Dec. 2024 (MXN167.03 Mil) to Dec. 2025 (MXN123.30 Mil).

Fulgent Genetics Other Current Receivables Related Terms

Fulgent Genetics Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Fulgent Genetics's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fulgent Genetics Other Current Receivables Chart

Fulgent Genetics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 89.91 435.95 107.16 167.03 123.30

Fulgent Genetics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 183.35 147.72 138.10 123.30 116.47
MEX:FLGT
56GF Score
Fulgent Genetics Inc MEX:FLGT
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fulgent Genetics Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of MXN116 Mil mean?
Fulgent Genetics (MEX:FLGT) has a Other Current Receivables of MXN116 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Fulgent Genetics and its competitors.
Is Fulgent Genetics' Other Current Receivables too high?
Fulgent Genetics' current Other Current Receivables is MXN116 Mil. Overall, Fulgent Genetics has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Fulgent Genetics' Other Current Receivables compare to MYGN and CSTL?
Fulgent Genetics' Other Current Receivables of MXN116 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Medical Diagnostics & Research company?
A good Other Current Receivables depends on the Medical Diagnostics & Research industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Fulgent Genetics and its competitors. Fulgent Genetics's current Other Current Receivables is MXN116 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fulgent Genetics stock overvalued right now?
Based on GuruFocus' analysis, Fulgent Genetics (MEX:FLGT) is currently considered Possible Value Trap. The stock's GF Value™ is MXN734.64, compared to a current price of MXN372.00 — trading 49.4% below its estimated fair value. The current Other Current Receivables is MXN116 Mil. Fulgent Genetics' overall GF Score™ is 56/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Fulgent Genetics (MEX:FLGT), the current Other Current Receivables is MXN116 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fulgent Genetics (MEX:FLGT) Overvalued in 2026?

Based on GuruFocus' analysis, Fulgent Genetics stock appears to be undervalued. The current stock price of MXN372.00 is trading 49.4% below its estimated GF Value™ of MXN734.64. GuruFocus considers Fulgent Genetics to be Possible Value Trap.

Key valuation signals for MEX:FLGT:

  • Other Current Receivables: MXN116 Mil
  • GF Value™: MXN734.64 vs. price of MXN372.00 (49.4% below fair value)
  • GF Score™: 56/100 with 4 warning signs

No single metric tells the full story. See the MEX:FLGT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fulgent Genetics Business Description

Other Exchanges FLGT:USA
Address 4399 Santa Anita Avenue, El Monte, CA, USA, 91731
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.
56GF Score

Get the complete analysis for MEX:FLGT

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN372.00
Price
MXN734.64
GF Value